These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4871194)

  • 1. The effect of pyridoxal-5-phosphate on porphyrin excretion and serum iron level in porphyria cutanea tarda.
    Petres J; Schröder K; Consbruch U; Ladner HA
    Ger Med Mon; 1968 Feb; 13(2):73-6. PubMed ID: 4871194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Porphyrin excretion and blood iron under pyridoxal-5-phosphate administration in porphria cutanea tarda].
    Petres J; Schröder K; Consbruch U; Ladner HA
    Dtsch Med Wochenschr; 1967 Aug; 92(34):1498-502. PubMed ID: 6047898
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary excretion of porphyrins in two cases of porphyria cutanea tarda during a period of various treatments.
    Eriksen L; Thune PO
    Scand J Clin Lab Invest; 1978 May; 38(3):273-7. PubMed ID: 307270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyridoxal-5-phosphate in porphyria cutanea tarda].
    Vibrans U; Hilgenfeldt J; Petres J
    Hautarzt; 1972 Apr; 23(4):155-60. PubMed ID: 5048343
    [No Abstract]   [Full Text] [Related]  

  • 5. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Porphyria cutanea tarda - review of the current therapy].
    Stekl D
    Med Arh; 1975; 29(2):133-5. PubMed ID: 1048996
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic alkalinization therapy in porphyria cutanea tarda.
    Perry HO; Mullanax MG; Wiegand SE
    Arch Dermatol; 1970 Oct; 102(4):359-67. PubMed ID: 5470946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of therapy in acquired porphyria cutanea tarda.
    Hoo TT
    S Afr Med J; 1971 Sep; ():197-9. PubMed ID: 5150278
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
    Marchesi L; Di Padova C; Cainelli T; Reseghetti A; Di Padova F; Rovagnati P; Cantoni L
    Photodermatol; 1984 Dec; 1(6):286-92. PubMed ID: 6398430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbate status of patients with porphyria cutanea tarda symptomatica and its effect on porphyrin metabolism.
    Percy VA; Naidoo D; Joubert SM; Pegoraro RJ
    S Afr J Med Sci; 1975; 40(4):185-96. PubMed ID: 1209393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of serum and urinary porphyrin levels in porphyria cutanea tarda.
    Kalb RE; Grossman ME; Poh-Fitzpatrick MB
    Arch Dermatol; 1985 Oct; 121(10):1289-91. PubMed ID: 4037823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of porphyria cutanea tarda with chloroquine.
    Kordac V; Semrádová M
    Br J Dermatol; 1974 Jan; 90(1):95-100. PubMed ID: 4811840
    [No Abstract]   [Full Text] [Related]  

  • 15. [Letter: Porphyria cutanea tarda: normalization of porphyrin-excretion following treatment with p-amino-benzoic acid (Potaba) (author's transl)].
    Goerz G; Krieg T; Bolsen K
    Arch Dermatol Res (1975); 1976 Jun; 255(3):331-5. PubMed ID: 942260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up studies of porphyrin excretion in porphyria cutanea tarda treated with p-aminobenzoic acid.
    de Salamanca RE; Peña ML; Olmos A; Molina C; Ladero JM
    Ann Clin Res; 1980 Dec; 12(6):279-81. PubMed ID: 6972189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of clinical and chemical studies in porphyria cutanea tarda].
    Formanek I; Niebauer G
    Wien Z Inn Med; 1966 Nov; 47(11):438-44. PubMed ID: 6005177
    [No Abstract]   [Full Text] [Related]  

  • 18. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD; Jones KG
    Can Med Assoc J; 1979 Apr; 120(7):803-7. PubMed ID: 427687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and biological effects of chelating agents in porphyria cutanea tarda].
    Thivolet J; Perrot H; Mallein R; Sabater P
    Presse Med (1893); 1968 Feb; 76(8):367-70. PubMed ID: 4967022
    [No Abstract]   [Full Text] [Related]  

  • 20. [Does paraneoplastic porphyria cutanea tarda exist?].
    Köstler E
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):35-40. PubMed ID: 3371236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.